13D Filing: Tang Capital Partners LP and La Jolla Pharmaceutical Co (LJPC)

Page 7 of 8 – SEC Filing

Tang Capital Management, LLC is the general partner of Tang Capital Partners, LP, and Kevin C. Tang is the manager of Tang Capital Management, LLC. The Kevin C. Tang Foundation, Inc. is a private foundation for which Kevin C. Tang serves as President and Treasurer. Mr. Tang has voting and dispositive power over the shares held by this foundation, which is a Delaware not-for-profit corporation. The mailing address of all of the foregoing persons and entities is c/o Tang Capital Management, LLC, 4747 Executive Drive, Suite 510, San Diego, CA 92121.

The percentages used herein for Tang Capital Partners, LP and Tang Capital Management, LLC are based upon 25,567,529 shares of Common Stock outstanding as set forth in the Issuer’s Form 424B5 that was filed with the SEC on March 16, 2018. The percentages used herein for Kevin C. Tang are based upon 25,615,529 shares of Common Stock outstanding (25,567,529 shares of Common Stock outstanding as described in the foregoing sentence, plus an additional 48,000 shares of Common Stock issuable upon exercise of options granted to Kevin C. Tang).
(b)       Voting and disposition powers:
Sole power to vote or direct the vote:
Tang Capital Partners, LP
0 shares
Tang Capital Management, LLC
0 shares
Kevin C. Tang
48,000 shares
Shared power to vote or direct the vote:
Tang Capital Partners, LP
4,138,893 shares
Tang Capital Management, LLC
4,138,893 shares
Kevin C. Tang
4,138,893 shares
Sole power to dispose or direct the disposition:
Tang Capital Partners, LP
0 shares
Tang Capital Management, LLC
0 shares
Kevin C. Tang
48,000 shares
Shared power to dispose or direct the disposition:
Tang Capital Partners, LP
4,138,893 shares
Tang Capital Management, LLC
4,138,893 shares
Kevin C. Tang
4,138,893 shares
(c)      Other than the purchases described in Item 3, none of the Reporting Persons have effected any transaction in the Issuer’s Common Stock within the last 60 days.
(d)      N/A.
(e)       N/A.

Follow La Jolla Pharmaceutical Co (NASDAQ:LJPC)